↓ Skip to main content

Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials

Overview of attention for article published in Frontiers in Aging Neuroscience, May 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
29 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials
Published in
Frontiers in Aging Neuroscience, May 2023
DOI 10.3389/fnagi.2023.1169499
Pubmed ID
Authors

Yue Qiao, Yuewei Chi, Qingyuan Zhang, Ying Ma

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 8%
Student > Ph. D. Student 5 7%
Student > Bachelor 4 5%
Other 3 4%
Student > Postgraduate 3 4%
Other 6 8%
Unknown 49 64%
Readers by discipline Count As %
Medicine and Dentistry 7 9%
Biochemistry, Genetics and Molecular Biology 5 7%
Neuroscience 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Psychology 2 3%
Other 9 12%
Unknown 46 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2024.
All research outputs
#1,390,923
of 26,621,386 outputs
Outputs from Frontiers in Aging Neuroscience
#333
of 5,734 outputs
Outputs of similar age
#28,417
of 416,135 outputs
Outputs of similar age from Frontiers in Aging Neuroscience
#10
of 182 outputs
Altmetric has tracked 26,621,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,734 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 416,135 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 182 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.